Precision Lung Cancer Survivorship Care Intervention (NCT05857995)
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities
🩺 Plain-English Summary (8th-Grade Level)
The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (5 items).
Location: Markey Cancer Center — Lexington, Kentucky
Age range: 18 Years
🧪 Interventions in This Study
- Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program (BEHAVIORAL)
- Enhanced Usual Care (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Have significant psychiatric disturbance that requires a higher level of care
- Have substance abuse/dependence that requires a higher level of care
- Are participating in another lung cancer survivorship care intervention
- Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Markey Cancer Center — Lexington, Kentucky
📞 Contact the Study Coordinator
Phone: (859) 323-7224
Email: jerod.stapleton@uky.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer
- Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
- Study of Trilaciclib and Lurbinectidin — Lebanon, New Hampshire
- Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT — Boston, Massachusetts
- Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer — Rochester, New York
- Early Detection of Lung Cancer — Nashville, Tennessee
Explore by condition: All Lung Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.